Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Sir Dave Stuart, FRS FMedSci, NDM’s Professor of Structural Biology, knighted for services to medical research and the scientific community.

Dave is the Founder and Director of the Division of Structural Biology (STRUBI) and Oxford Centre for EM imaging of Infectious Particles (OPIC) and Life Sciences’ Director at the Diamond Light Source. His work ranges across virus-receptor interactions, basic puzzles of virus assembly and studying virus evolution. He has made numerous contributions to the understanding of the structure of viruses, structural vaccinology and anti-viral drug discovery. 

Over the last year, he has led a huge collaborative effort between Diamond, Rosalind Franklin Institute and the University of Oxford studying the structures of SARS-Cov-2 protein structures, and particularly the interaction of the virus’ Spike receptor protein with patient-derived antibodies. This knowledge is being used in anti-COVID19 drug development and tracking and evaluating the significance of new variants. All this work draws heavily on national and international collaborations with academic and industrial partners. Dave has also helped to develop and establish the high-throughput anti-COVID19 antibody screening platform in NDM, which is used by the Office of National Statistics to screen the UK population.

Similar stories

Lateral flow devices detect most infectious COVID-19 cases and could allow a safer relaxation of the current lockdown

News

Researchers from NDM's Big Data Institute working with Public Health England and NHS Test and Trace, have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others, and if lateral flow tests are sufficient in detecting those who are most infectious

National consortium to study threats of new SARS-CoV-2 variants

News

A new national research project to study the effects of emerging mutations in SARS-CoV-2 will be launched with £2.5 million funding from UK Research and Innovation (UKRI).

Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine

News

The Nuffield Department of Medicine welcomes the news that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK.

Professor Susie Dunachie awarded flagship NIHR career development award

News

Susie Dunachie joins a prestigious group of leading health researchers in the latest cohort of NIHR Global Research Professors. These awards fund research leaders of the future to promote effective translation of research and to strengthen health, public health and care research leadership at the highest academic levels. Research conducted by Global Research Professors directly benefits people in LMICs. A Consultant in Infectious Diseases and Medical Microbiology, Susie works on the development of a vaccine to prevent death from melioidosis in people with type 2 diabetes mellitus in LMICs, and supports vaccine research in Thailand.

RECOVERY trial finds no benefit from azithromycin in patients hospitalised with COVID-19

News

RECOVERY reports absence of a benefit from Azithromycin. The latest result from the NDM/NDPH RECOVERY trial shows the widely administered administration of a broad-spectrum antibiotic makes no difference to the routine outcome in hospitalised COVID19 disease. Results on other therapies are likely to follow in the coming weeks.

National COVID-19 Infections Survey reveals changes to pandemic over time

News

Data from the National COVID-19 Infection Survey, done in partnership between the University of Oxford, the Office of National Statistics, Public Health England, University of Manchester and the Wellcome Trust, has revealed detailed characteristics of England’s coronavirus pandemic, including which factors have contributed most to case numbers over different phases and the prevalence of asymptomatic infections.